Cargando…
A fusion of CD63–BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis
BACKGROUND: Recently, fusion variants of the breast cancer anti-oestrogen-resistance 4 (BCAR4) gene were recurrently discovered in lung adenocarcinoma from the genome-wide studies. However, the functional characterisation of BCAR4 fusion has not been investigated. METHODS: Based on the analysis of R...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782829/ https://www.ncbi.nlm.nih.gov/pubmed/33204025 http://dx.doi.org/10.1038/s41416-020-01146-3 |